Skip navigation
CBI
The Leader in Conferences for the Pharmaceutical Industry

7th Annual Rare Disease and Orphan Drug Leadership Congress

Ensure Access to Orphan Drug Therapies through Collaborative Efforts with Government, Researchers and Patient Groups

July 18, 2012 - July 19, 2012
  • Philadelphia, Pennsylvania

Who Should Attend

You will benefit from attending this event if you are an executive or senior level director from the biotech, pharmaceutical or medical device/diagnostics industries with responsibilities or involvement in the following areas:

  • Regulatory Affairs
  • Marketing
  • Reimbursement
  • Clinical Development
  • Clinical Operations
  • Clinical Research
  • Pre-Clinical Research
  • Global Branding
  • Pricing
  • Research & Development (Domestic & Global)
  • Product Management
  • Forecasting and Portfolio

This summit will also benefit consultants, CROs, CMOs, third party payers, specialty pharmacy and distribution companies working in the rare and orphan disease arena.

Craig Kephart
Kristina Broadbelt
Roger J. Garceau M.D., FAAP
Simon Estcourt
Ron C. Falcone Ph.D.
Jack Mycka
Douglas Paul Pharm.D., MS
Marc Boutin JD
John Lagus
Cliff Stearns
Kristin Keller
Emil D. Kakkis M.D., Ph.D.
Ann Brazeau
Peter H. Nalen
Jill Panetta Ph.D.